[Federal Register Volume 87, Number 67 (Thursday, April 7, 2022)]
[Notices]
[Page 20464]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-07368]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-988]


Bulk Manufacturer of Controlled Substances Application: Purisys, 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Purisys, LLC. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTAL INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before June 6, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before June 6, 2022.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 21, 2022, 1550 Olympic Drive, Athens, Georgia 
30601-1602, applied to be registered as a bulk manufacturer of the 
following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Cathinone...............................    1235  I
Gamma Hydroxybutyric Acid...............    2010  I
Lysergic acid diethylamide..............    7315  I
Marihuana Extract.......................    7350  I
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
2,5-Dimethoxyamphetamine................    7396  I
3,4-Methylenedioxy                          7400  I
 amphetamine............................
5-Methoxy-3,4-methylenedioxy amphetamine    7401  I
3,4-Methylenedioxy                          7405  I
 methamphetamine........................
5-Methoxy-N-N-dimethyl                      7431  I
 tryptamine.............................
Diethyltryptamine.......................    7434  I
Dimethyltryptamine......................    7435  I
Psilocybin..............................    7437  I
Psilocyn................................    7438  I
Codeine-N-oxide.........................    9053  I
Dihydromorphine.........................    9145  I
Hydromorphinol..........................    9301  I
Morphine-N-oxide........................    9307  I
Normorphine.............................    9313  I
Norlevorphanol..........................    9634  I
Codeine.................................    9050  II
Dihydrocodeine..........................    9120  II
Oxycodone...............................    9143  II
Hydromorphone...........................    9150  II
Hydrocodone.............................    9193  II
Levorphanol.............................    9220  II
Morphine................................    9300  II
Oripavine...............................    9330  II
Thebaine................................    9333  II
Opium tincture..........................    9630  II
Opium, powdered.........................    9639  II
Opium, granulated.......................    9640  II
Oxymorphone.............................    9652  II
Noroxymorphone..........................    9668  II
Alfentanil..............................    9737  II
Sufentanil..............................    9740  II
Carfentanil.............................    9743  II
Tapentadol..............................    9780  II
Fentanyl................................    9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for internal use intermediates or for sale to its customers. 
The company plans to manufacture the above-listed controlled substances 
as clinical trial and starting materials to make compounds for 
distribution to its customers. No other activities for these drug codes 
are authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-07368 Filed 4-6-22; 8:45 am]
BILLING CODE P